Market Overview According to the research report, the global intravenous immunoglobulin market was valued at USD 12.66 billion in 2023 and is expected to reach USD 24.13 billion by 2032, to grow at a CAGR of 7.50% during the forecast period. Intravenous immunoglobulin (IVIG) is a blood plasma-derived product composed of pooled immunoglobulin G (IgG) antibodies extracted from the...